Evelyn Palmer

Royal Victoria Infirmary — United Kingdom

Medicine · Health Sciences

8h-index274citations24works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(10), Palliative Care and End-of-Life Issues(5), Sarcoidosis and Beryllium Toxicity Research(4), Systemic Sclerosis and Related Diseases(3), Chronic Obstructive Pulmonary Disease (COPD) Research(2)

Publications24 total

Cluster analysis to phenotype sarcoidosis using British Thoracic Registry data
2025
Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry
BMJ Open Respiratory Research·2025· 2 citedOpen Access
P85 Outcomes for patients with lung cancer and ILD: a retrospective review of cases discussed at a regional ILD-MDT
2024
Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry
2024
Idiopathic Pulmonary Fibrosis in the United Kingdom: Findings from the first decade of the largest single-country IPF Registry
2024
M6 Critically examining the end of life care of people with interstitial lung disease: views of patients, families and healthcare professionals
2023· 1 citedOpen Access
Correction: Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
Pulmonary Therapy·2023Open Access
Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
Pulmonary Therapy·2023· 50 citedOpen Access
When should palliative care be introduced for people with progressive fibrotic interstitial lung disease? A meta-ethnography of the experiences of people with end-stage interstitial lung disease and their family carers
Palliative Medicine·2022· 6 citedOpen Access
O-6 Critically examining the experience of end of life care for people with interstitial lung disease: views of patients, families and healthcare professionals
Oral Presentations·2022Open Access
32 Critically examining the experience of end of life care for people with interstitial lung disease: views of patients, families and healthcare professionals
2022
Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis
Palliative Medicine·2021· 11 citedOpen Access
From Ta-Kesh to Ta-Kush: The affordances of digital, haptic visualisation for heritage accessibility
Digital Applications in Archaeology and Cultural Heritage·2020· 11 cited
Rheumatoid arthritis related interstitial lung disease – improving outcomes over 25 years: a large multicentre UK study
Lara D. Veeken·2020· 79 citedOpen Access
49 Review of potential geographical disparities in access to anti-fibrotic medication and clinic-based specialist palliative care for patients with idiopathic pulmonary fibrosis
2019Open Access
Optimising the management of patients with difficult asthma.
PubMed·2015· 1 cited
068. Cyclophosphamide in the Treatment of Severe Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Lara D. Veeken·2015· 1 citedOpen Access
Late failure of non-invasive ventilation in COPD
2014· 1 cited
OP0037 Pulsed Cyclophosphamide in the Treatment of Rheumatoid Arthritis-Related Interstitial Lung Disease (RA-ILD)
Annals of the Rheumatic Diseases·2014· 14 cited
ASD diagnostic assessments: Improvements since NAP-C publication
2011· 50 cited
page 1 of 2Next →

Frequent Co-authors

Ian Forrest(6), Shelina Visram(5), Anne-Marie Bourke(5), Catherine Exley(5), Maria Loughenbury(4), Iain Stewart(4), Nazia Chaudhuri(4), Clare Hodkinson(4), Paul Minnis(4), Clive Kelly(3), Felix Woodhead(3), David Middleton(3), Julie Dawson(3), Gouri Koduri(3), Ahmed Fahim(3), Sarah Agnew(3), Howard Almond(3), Leo Casimo(3), Sarah Haney(3), Ling‐Pei Ho(3)